Start with what really counts
Don’t get dazzled by fancy brochures. Compare the parts that make or break a study: clear study design, honest data access, and the lab’s way of handling surprises. Folks who run trials mean business. If you’re lining up a preclinical CRO, put those items at the top of your list.
Compare scientific competence, not slogans
Look for track records, not taglines. Who designed their recent studies? Do they publish methods or share SOP excerpts? Prefer teams with named scientists and pathologists you can vet. Short answers, quick references, sample reports — those show a shop that knows its work.
Histology and pathology: check the microscope
Tissue work tells the tale. Ask for slide photos, staining QC logs, and pathologist sign-off templates. The Society of Toxicologic Pathology annual meeting has flagged consistency in tissue processing as a recurring problem, so don’t take neat phrasing for granted. Labs that can point to reproducible runs and clear specimen chains usually stand up under scrutiny. If you need a focused capability, ask about their preclinical histology services and where they run those workflows.
Data integrity and reporting practices
Raw files matter. Demand original images, audit trails, and exportable datasets. A report that hides raw data is trouble. Check timestamps, version notes, and how they annotate changes. Good suppliers let you access a result before final sign-off. That saves time and arguments later.
Regulatory readiness and quality assurance
GLP claims get tossed around. Verify the scope of their GLP work, the QA audits they’ve passed, and who signs regulatory packages. Look for a written deviation policy and corrective action records. If a vendor can’t show documented QA steps, assume extra work for your team.
Turnaround, capacity, and real costs
Fast isn’t always better. Ask how they handle bottlenecks: backup equipment, cross-trained staff, third-shift runs. Get timelines tied to milestones, not vague phrases. Request a pricing breakdown — per-sample fees, setup costs, revision charges. Hidden fees hide trouble.
Common pitfalls people miss
They skip validation details. They accept summary-only reports. They forget blinding and randomization records. They assume chain-of-custody without seeing it. These slip-ups blow results or delay filing. Catch them early by asking simple, pointed questions and demanding sample artifacts.
How to decide — a quick checklist
Match your study needs against: protocol clarity, pathologist credentials, raw data access, documented QA, and realistic timelines. Rank suppliers on those points. Don’t chase the lowest number alone; pick the partner who reduces redo risk.
Close-up: practical judgment
You’ve read the checklist. Use it like a farmer uses a soil test. Ask for the proof that matters. Expect clear records and steady practices. Those are the traits that keep studies moving and regulators satisfied. That same practical standard is what you’ll find reflected in labs with steady preclinical pipelines, such as KCI Biotech.